Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Scholar Rock	Coherus BioSciences	Vaxcyte	Curis	Cortexyme
Symbol	NASDAQ:SRRK	NASDAQ:CHRS	NASDAQ:PCVX	NASDAQ:CRIS	NASDAQ:CRTX
Price Information
Current Price	$28.60	$13.85	$18.67	$16.27	$36.57
52 Week Range	Buy	Buy	Buy	Buy	Hold
MarketRank™
Overall Score	1.5	1.4	1.7	0.9	1.3
Analysis Score	3.5	3.4	3.5	1.5	3.1
Community Score	2.3	2.5	2.9	2.6	2.6
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.8	0.0	1.7	0.0	0.8
Earnings & Valuation Score	0.6	1.3	0.6	0.6	0.0
Analyst Ratings
Consensus Recommendation	Buy	Buy	Buy	Buy	Hold
Consensus Price Target	$61.60	$25.00	$48.00	$14.60	$50.00
% Upside from Price Target	115.38% upside	80.57% upside	157.10% upside	-10.26% downside	36.72% upside
Trade Information
Market Cap	$983.64 million	$1.05 billion	$958.80 million	$1.49 billion	$1.08 billion
Beta	0.35	1.57	N/A	3.29	0.95
Average Volume	288,005	1,226,465	371,520	2,603,553	280,174
Sales & Book Value
Annual Revenue	$20.49 million	$356.07 million	N/A	$10 million	N/A
Price / Sales	48.01	2.95	N/A	148.90	N/A
Cashflow	N/A	$1.04 per share	N/A	N/A	N/A
Price / Cash	N/A	13.36	N/A	N/A	N/A
Book Value	$3.80 per share	$1.50 per share	N/A	($1.02) per share	$4.30 per share
Price / Book	7.53	9.23	N/A	-15.95	N/A
Profitability
Net Income	$-51,000,000.00	$89.83 million	$-50,270,000.00	$-32,140,000.00	$-36,980,000.00
EPS	($1.85)	$1.23	N/A	($0.86)	($1.94)
Trailing P/E Ratio	N/A	6.79	0.00	N/A	N/A
Forward P/E Ratio	N/A	15.73	N/A	N/A	N/A
P/E Growth	N/A	9.34	N/A	N/A	N/A
Net Margins	-365.84%	33.06%	N/A	-279.33%	N/A
Return on Equity (ROE)	-80.16%	90.98%	N/A	N/A	-37.78%
Return on Assets (ROA)	-41.33%	27.33%	N/A	-81.32%	-35.24%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	1.58%	N/A	N/A	N/A
Current Ratio	3.63%	5.45%	10.12%	3.10%	8.71%
Quick Ratio	3.63%	5.18%	10.12%	3.10%	8.71%
Ownership Information
Institutional Ownership Percentage	61.87%	N/A	74.08%	34.66%	55.48%
Insider Ownership Percentage	24.60%	15.86%	N/A	7.34%	19.80%
Miscellaneous
Employees	119	310	58	28	37
Shares Outstanding	34.39 million	75.75 million	51.36 million	91.52 million	29.59 million
Next Earnings Date	5/13/2021 (Estimated)	8/5/2021 (Estimated)	8/11/2021 (Estimated)	5/12/2021 (Confirmed)	8/16/2021 (Estimated)
Optionable	Not Optionable	Optionable	Not Optionable	Optionable	Not Optionable

Source	Headline
	Cortexyme Provides Business Update and Reports First Quarter 2021 Results - Yahoo Finance finance.yahoo.com - May 12 at 9:00 PM
	Cortexyme, Inc. (NASDAQ:CRTX) CEO Casey Lynch Sells 30,000 Shares americanbankingnews.com - May 12 at 5:06 PM
	Cortexyme (NASDAQ:CRTX) Releases Quarterly Earnings Results, Misses Estimates By $0.08 EPS americanbankingnews.com - May 11 at 3:22 PM
	Cortexyme (NASDAQ:CRTX) Trading Up 6.8% americanbankingnews.com - May 11 at 11:42 AM
	How Much Are Cortexyme, Inc. (NASDAQ:CRTX) Insiders Spending On Buying Shares? - Yahoo Finance finance.yahoo.com - May 10 at 9:34 PM
	Cortexyme EPS beats by $0.02 - Seeking Alpha seekingalpha.com - May 10 at 9:34 PM
	Cortexyme Posts Q1 Loss Per Share $0.78 - CMLViz.com - CML News cmlviz.com - May 10 at 4:33 PM
	Cortexyme Provides Business Update and Reports First Quarter 2021 Results - BioSpace biospace.com - May 10 at 4:33 PM
	Cortexyme Provides Business Update and Reports First Quarter 2021 Results finance.yahoo.com - May 10 at 4:33 PM
	How Much Are Cortexyme, Inc. (NASDAQ:CRTX) Insiders Spending On Buying Shares? finance.yahoo.com - May 9 at 11:45 AM
	Checking In On Cortexyme - Seeking Alpha seekingalpha.com - May 6 at 4:50 PM
	Checking In On Cortexyme seekingalpha.com - May 6 at 2:15 PM
	Is Cortexyme Inc (CRTX) Stock at the Top of the Biotechnology Industry? - InvestorsObserver investorsobserver.com - May 4 at 3:10 PM
	Cortexyme (NASDAQ:CRTX) Stock Price Down 7.4% americanbankingnews.com - May 4 at 1:16 PM
	Cortexyme to Present at the BofA Securities 2021 Healthcare Conference on May 11, 2021 - Yahoo Finance finance.yahoo.com - May 4 at 10:10 AM
	Cortexyme to Present at the BofA Securities 2021 Healthcare Conference on May 11, 2021 finance.yahoo.com - May 4 at 10:10 AM
	Cortexyme (NASDAQ:CRTX) Shares Gap Down to $38.26 americanbankingnews.com - April 26 at 12:10 PM
	Where Does Cortexyme Inc (CRTX) Stock Fall in the Biotechnology Field After It Has Risen 8.93% This Week? - InvestorsObserver investorsobserver.com - April 21 at 2:09 PM
	Should You Buy Cortexyme Inc (CRTX) Stock After it Is Up 6.92% in a Week? - InvestorsObserver investorsobserver.com - April 20 at 2:04 PM
	Cortexyme (NASDAQ:CRTX) Stock Price Up 4.5% americanbankingnews.com - April 20 at 11:58 AM
	Cortexyme Inc (CRTX) is down -0.97% in a Week, Should You Sell? - InvestorsObserver investorsobserver.com - April 13 at 3:10 PM
	Where Will Cortexyme Inc (CRTX) Stock Go Next After It Is Lower By 6.77% in a Week? - InvestorsObserver investorsobserver.com - April 9 at 8:01 PM
	Is Cortexyme Inc (CRTX) a Stock to Watch After Losing -3.90% This Week? - InvestorsObserver investorsobserver.com - March 31 at 3:32 PM
	Cortexyme Inc (CRTX) Stock Is Up 0.71% This Week: Buy, Hold, or Sell? - InvestorsObserver investorsobserver.com - March 26 at 3:02 PM
	Thursday 3/25 Insider Buying Report: CRTX marketwatch.com - March 26 at 4:48 AM

Date	Company	Brokerage	Action
1/25/2021	Scholar Rock	BMO Capital Markets	Boost Price Target
1/21/2021	Scholar Rock	Wedbush	Boost Price Target
1/11/2021	Scholar Rock	Credit Suisse Group	Initiated Coverage
1/6/2021	Scholar Rock	JPMorgan Chase & Co.	Initiated Coverage
10/27/2020	Scholar Rock	Robert W. Baird	Reiterated Rating
11/19/2019	Scholar Rock	Cowen	Reiterated Rating
6/18/2018	Scholar Rock	Jefferies Financial Group	Initiated Coverage
5/7/2021	Coherus BioSciences	Maxim Group	Initiated Coverage
5/7/2021	Coherus BioSciences	HC Wainwright	Lower Price Target
2/25/2021	Coherus BioSciences	Citigroup	Lower Price Target
11/19/2020	Coherus BioSciences	Mizuho	Lower Price Target
7/16/2020	Coherus BioSciences	Bank of America	Initiated Coverage
4/17/2020	Coherus BioSciences	SunTrust Banks	Initiated Coverage
8/12/2019	Coherus BioSciences	Barclays	Set Price Target
8/14/2020	Vaxcyte	Needham & Company LLC	Reiterated Rating
7/7/2020	Vaxcyte	Cantor Fitzgerald	Initiated Coverage
3/30/2021	Curis	B. Riley	Initiated Coverage
3/17/2021	Curis	Jonestrading	Boost Price Target
7/29/2020	Curis	Laidlaw	Initiated Coverage
12/11/2020	Cortexyme	Smith Barney Citigroup	Initiated Coverage
12/11/2020	Cortexyme	Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell	Initiated Coverage
9/24/2020	Cortexyme	Lifesci Capital	Reiterated Rating
5/13/2020	Cortexyme	Canaccord Genuity	Reiterated Rating
6/3/2019	Cortexyme	JMP Securities	Initiated Coverage

(Data available from 5/12/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources